Hyperinflation Respiratory Therapies in Cardiac Surgery Patients
Hyperinflation Respiratory Therapies in Cardiac Surgery Patients: A Randomized, Observer-Blinded, Prospective Clinical Trial
University of Texas Southwestern Medical Center
324 participants
Jun 15, 2020
INTERVENTIONAL
Conditions
Summary
The purpose of this prospective randomized clinical trial is to evaluate three different types of hyperinflation respiratory therapies, Intermittent Positive Pressure Breathing (IPPB), Intermittent positive end expiratory pressure (EzPAP), Metaneb. Investigators will examine which hyperinflation therapy provides better lung expansion and may improve lung recovery after surgery.
Eligibility
Inclusion Criteria3
- Age 18 years and older
- Admitted to Cardiovascular ICU (CVICU) after coronary artery bypass grafting (CABG), isolated valve repair/replacement, or CABG + valve repair/replacement
- Cardiac surgery performed via median sternotomy
Exclusion Criteria3
- BMI>40
- Refusal to be consented
- Prior or current lung transplant patients
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Patient will receive 10 min EzPAP 4 times daily
Patient will receive 10 min Metaneb 4 times daily
Patient will receive 10 min IPPB 4 times daily
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04164173